Policy Evaluation for Regulating Toxic Traditional Chinese Medicines in Taiwan. [PDF]
Lan YS, Chen PH, Chen YP.
europepmc +1 more source
Geometric reconstruction of the left ventricle on a beating heart through a minimally invasive approach from the left anterolateral thoracotomy: case report. [PDF]
Aigumov RN +8 more
europepmc +1 more source
Comparative Efficacy and Safety of Vasopressors and Inotropes in Acute Myocardial Infarction-Related Cardiogenic Shock: A Systematic Review and Network Meta Analysis of Randomized and Observational Studies. [PDF]
Ali AOH +10 more
europepmc +1 more source
Cardiac glycosides: Looking beyond heart failure and atrial fibrillation.
Omole JG +8 more
europepmc +1 more source
Prophylactic Use of Lipid Emulsion Therapy After Inadvertent Administration of 0.5% Ropivacaine for a Bier Block: A Case Report. [PDF]
Luong A +7 more
europepmc +1 more source
Antioxidant and Antibacterial Potential of <i>Passiflora edulis</i> (Passion Fruit) at Three Ripening Stages for Waste Valorization. [PDF]
Quirós-Cubillo M +4 more
europepmc +1 more source
Recent progress in the use of periplocin, periplocymarin and periplogenin in cancer treatment. [PDF]
Sun X +5 more
europepmc +1 more source
Comparative cardioprotective effects of Kuanxiong Aerosol and its individual components in a rat model of acute myocardial infarction. [PDF]
Qian K +10 more
europepmc +1 more source
Dual functional polyherbal silver nanoparticles for efficient dye degradation and Fe<sup>3+</sup> ion detection. [PDF]
Vyavahare A +5 more
europepmc +1 more source
Related searches:
The therapeutic potential of novel cardiotonic agents
Expert Opinion on Investigational Drugs, 2003During the course of treatment of heart failure patients, cardiotonic agents are inevitable for improvement of myocardial dysfunction. Clinically available agents, such as beta-adrenoceptor agonists and selective phosphodiesterase 3 inhibitors, act mainly via cyclic AMP/protein kinase A-mediated facilitation of Ca(2+) mobilisation (upstream mechanism).
openaire +4 more sources

